Neurology residents explore Parkinson's care, research advances and career opportunities at the 2026 MDS-PAS Movement Disorders School.

This election season, California voters are considering Proposition 38, a ballot measure that would authorize $8.4 billion in state bonds for immunology and immunotherapy research at California ...

Registration for the 2026 Parkinson’s Disease Therapeutics Conference is currently sold out. To stay up to date with the latest from the Foundation, sign up for our Researcher and Clinician Newsletter ...

Observational studies do not test drugs or treatments. Instead, researchers examine participants’ health over a certain time period. With observational studies, researchers collect data to advance ...

Parkinson’s disease (PD) is different for everyone. How it affects your ability to work depends on the type and severity of your symptoms and the kind of work you do. Some people with Parkinson’s are ...

A DAF is your personal charitable savings account. You contribute money or assets now, and then recommend grants to causes you care about — including MJFF — whenever you’re ready. DAFs give you ...

The Foundation leads a global consortium of over 2,000 researchers, facilitating scientific exchange and collaboration to accelerate preclinical research and better understand Parkinson’s disease ...

Dr. Alastair Noyce is a Professor of Neurology and Neuroepidemiology at the Wolfson Institute of Population Health, Queen Mary University of London. He is a consultant neurologist at Barts Health NHS ...

Patrik Brundin joined the Van Andel Institute in 2012, where he is deputy chief scientific officer and directs the Parkinson’s Disease (PD) Center. He earned a PhD in 1988 and an MD in 1992 from Lund ...

In this post I’m discussing a substance you may have heard of — glutathione. It’s made naturally by the body but is also available in certain foods and over-the-counter supplements. Glutathione levels ...

Do cholesterol-lowering medicines, called statins, decrease risk of Parkinson’s? Statins lower cholesterol with the goal of decreasing risk of heart disease and stroke. But they also lower ...

Update as of September 17, 2024: Join the 2024 Parkinson's National Day of Action by signing a petition to urge the White House to ban paraquat. Update as of April 1, 2024: In partnership with the ...